Different metastatic potentials of ras- and src-transformed BALB/c 3T3 A31 variant cells

M Tatsuka1, T Ota, N Yamagishi

  • 1Department of Molecular Virology and Oncology, Cancer Research Institute, Kanazawa University, Japan.

Insights

Tumorigenic cells lacking metastatic potential were created using the c-Ha-ras oncogene. The v-src oncogene induced metastatic capabilities, offering a new model for studying cancer metastasis signaling pathways.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Tumor cell metastasis is driven by signaling pathways distinct from those causing tumorigenicity.
  • Identifying these specific pathways is challenging because oncogenes often induce both phenotypes simultaneously.

Purpose of the Study:

  • To develop a cell model for studying metastatic potential.
  • To differentiate between oncogenes inducing tumorigenicity versus metastasis.

Main Methods:

  • Transfection of BALB/c 3T3 A31 variant cells with activated c-Ha-ras oncogene.
  • Transfection with v-src oncogene to assess metastatic potential induction.
  • Experimental metastasis assay in mice.
  • Cell motility and invasion assays using Matrigel.

Main Results:

  • c-Ha-ras transfectants were tumorigenic but non-metastatic, exhibiting stable phenotypes.
  • v-src transfection induced metastatic potential in both original and ras-transfected cells.
  • Src transfectants showed increased cell motility and Matrigel invasion compared to ras transfectants.

Conclusions:

  • The ras and src oncogene-transformed cells provide a valuable system for dissecting signaling cascades involved in tumor metastasis.
  • This model facilitates the identification of molecular mechanisms underlying metastatic potential.

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...